Gastrointestinal cancer, head and neck cancer, gynecological cancer, bone and soft tissue tumor, hematopoietic tumor, brain tumor, skin cancer, breast cancer
Conditions
Interventions
None listed
Sponsors
Nagasaki university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1:From April 1, 2010 to March 31, 2025, at Nagasaki University Hospital and joint research facilities, gastrointestinal cancer, head and neck cancer, gynecological cancer, bone and soft tissue tumor, hematopoietic tumor, brain tumor, skin cancer, Patients who underwent a pathological examination at the time of diagnosis and who underwent pathological examination at the time of diagnosis and who obtained tissues such as ascites or peritoneal washings at the time of surgery 2:Patients who are 20 years old or older during the target period 3:Sex: gender does not matter Patients who have received sufficient explanations before participating in this study and who have fully understood and obtained the written informed consent of the subject (or their sponsor) (patients who use residual samples Opt-out)
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expression of tumor antigens in tissues (MAGE-A4, NY-ESO-1, CEA, GD2), Analysis of tumor cells, immunocompetent cells, and cells involved in immunosuppression Expression analysis of immune-related genes and genes related to immunosuppression Analysis of immune reactions (humoral and cellular reactions) | — |
Countries
Japan
Contacts
Public ContactAkira Yoneda
Nagasaki University Department of Surgery
Outcome results
None listed